dynarex l-mesitran honeydev.dynarex.com/resources/sellsheet_productfamily/ss_honey...creates a moist...
TRANSCRIPT
Creates a moistwound environment,facilitates goodwound bedpreparation• Cleanses the wound,
reduces unpleasant odor• Debrides by autolysis,
aids eschar removal• Stimulates wound healing• Anti-infl ammatory
Package ReorderNo. Description Quantity Comparable
Products HCPCS
3071Tulle
Dynarex L-MesitranTulle Dressings
4˝ × 4˝10/10/Cs
Dukal Activon® Manuka Honey
TulleA4649
3073Border
Dynarex L-MesitranBorder Dressings
4˝ × 4˝10/10/Cs
Derma SciencesMediHoney®
HydrogelAdhesive
A6245
3075Hydro
Dynarex L-MesitranHydro-Active
Dressings4˝ × 4˝
10/10/Cs
Derma SciencesMediHoney®
HydrogelNon-Adhesive
A6242
3077Soft
Dynarex L-MesitranSoft Wound Gel
0.5 oz.24/1/Cs
MedlineTheraHoney®
GelA6250
3078Soft
Dynarex L-MesitranSoft Wound Gel
1.75 oz.24/1/Cs
MedlineTheraHoney®
GelA6250
Creates a moistwound environment,facilitates goodwound bedpreparation• Cleanses the wound,
reduces unpleasant odor• Debrides by autolysis,
aids eschar removal• Stimulates wound healing• Anti-infl ammatory
Package ReorderNo. Description Quantity Comparable
Products HCPCS
3071Tulle
Dynarex L-MesitranTulle Dressings
4˝ × 4˝10/10/Cs
Dukal Activon®
Manuka Honey Tulle
A4649
3073Border
Dynarex L-MesitranBorder Dressings
4˝ × 4˝10/10/Cs
Derma SciencesMediHoney®
HydrogelAdhesive
A6245
3075Hydro
Dynarex L-MesitranHydro-Active
Dressings4˝ × 4˝
10/10/Cs
Derma SciencesMediHoney®
HydrogelNon-Adhesive
A6242
3077Soft
Dynarex L-MesitranSoft Wound Gel
0.5 oz.24/1/Cs
MedlineTheraHoney®
GelA6250
3078Soft
Dynarex L-MesitranSoft Wound Gel
1.75 oz.24/1/Cs
MedlineTheraHoney®
GelA6250
is your one-stop medical supply company since 1967
10 Glenshaw Street • Orangeburg, NY 10962 • www.dynarex.com
For more information contact your local Dynarex® distributor sales representative.Or call 888-396-2739 to find your nearest distributor.
© 2017 Dynarex Corporation
WE CARE LIKE FAMILY™
Find us on:
3073 Border 3075 Hydro
3078 Soft
3077 Soft
3071 Tulle
Anti-infl ammatory
See website for our HydrocolloidDressings (Reorder Nos. 3014-3020)
Activon® is a registered trademark of Brightwake Ltd.MEDIHONEY® is a trademark of Comvita New Zealand Ltd. and is used with permission by Derma Sciences.
TheraHoney® is a registered trademark of Medline Industries, Inc.
See our website for other Marketing &Reference Materials and Related Links!
Dynarex L-Mesitran Honey
WE CARE LIKE FAMILY™
is your one-stop medical supply company since 1967Find us on:
rev. 0117
10 Glenshaw Street • Orangeburg, NY 10962 • www.dynarex.com
For more information contact your local Dynarex® distributor sales representative.Or call 888-396-2739 to find your nearest distributor.
© 2017 Dynarex Corporation
Dynarex L-Mesitran Tulle Dressings
4˝ × 4˝
Contain 40% honey (Soft ± 4 gram) pH ± 4.0. A synthetic gauze, conformable, easy to apply, can be used with L-Mesitran Soft. Wound types: Acute and chronic wounds, infected wounds with
(lots of) exudate.3071 HCPCS: A4649
Dynarex L-Mesitran Hydro-Active Dressings
4˝ × 4˝
Contain 30% Medical grade honey. They're a bacterial barrier, create a moist wound healing environment, and absorb low to high levels of exudate. Wound types: Acute and chronic wounds with light to high exudate. No contraindications known to date � ve days in-situ (depending on
amount of wound exudate.)3075 HCPCS: A6242
Dynarex L-Mesitran Border Dressings
4˝ × 4˝
Contain 30% Medical grade honey. They're a bacterial barrier, create a moist wound healing environment, and absorb low to high levels of exudate. Wound types: Acute and chronic wounds with light to high exudate. No contraindications known to date � ve days in-situ (depending on
amount of wound exudate.)3073 HCPCS: A6245
Dynarex L-MesitranSoft Wound Gel0.5 oz. & 1.75 oz.
Wound types/indications: Pressure ulcers, � rst & second degree burns, venous and arterial ulcers, diabetic (foot) ulcers, fungating wounds, donor sites, surgical wounds. Contraindications: None, although individuals with a known sensitivity to components should
be careful.3077 & 3078 HCPCS: A6250
Dynarex L-Mesitran
L-Mesitran Tulle
L-Mesitran Tulle is a non-adhering polyethylene dress-
ing, impregnated with L-Mesitran Soft gel that con-
tains 40% medical grade honey, hypo-allergenic lano-
lin, propylene glycol, PEG 4000, and vitamins C & E.
drawn from the surrounding tissues through osmosis.
By doing so, a moist wound healing environment is gnilaeh dnuow eht setalumits tnemnorivne sihT .detaerc
process.
L-Mesitran Tulle is an easy to use presentation as a sin-
gle use dressing and aims to provide patient comfort
and effective use of the gel. The Tulle dressing can stay
on the wound for several days and dressing changes
depend on the amount of wound exudates. The Tulle
will not adhere to the wound.
Indications
- Acute wounds such as cuts, abrasions and donor sites
burns (1st & 2nd degree)
- Chronic wounds e.g. pressure ulcers, venous and
arterial- Diabetic (foot) ulcers
- Fungating wounds (to help deodorise and/or debride)
- Colonised acute and (post-operative) surgical wounds
L-Mesitran Tulle provides a moist wound healing en-
vironment. This environment aids cleansing of the
wound and optimizes wound healing.
The gel does not adhere to the wound (it also prevents
the secondary dressing adhering to the wound). L-Me-
and reduces pain.
Case: Infected diabetic pressure ulcer
A female patient (65yrs) had a pressure sore (stage
II) on her right heel. The blister opened and got in-
fected, despite oral antibiotics. Due to the operation
the patient was weak, hardly had any appetite and was
depressed. She was also diabetic (Type 2) and her glu-
cose was deregulated after surgery.
MethodsAt the start of the honey treatment the wound was pro-
ducing high exudates. These exudates removed the
was changed 1x daily and covered with a foam dress-
only 3-4x per week. The dressing was applied directly
on the wound, after it was cleansed with tap water.
Results
and after approximately four weeks a clean and granu-
epithelised during the next three weeks and after sev-
en weeks the wound was fully healed (fig. 3). The
patient experienced no pain sensation during wear
time or at dressing changes. No maceration was ob-
served and the dressing created a moist wound envi-
ronment.
Product InformationTulle
1. First review
2. After 4 weeks
3. After 7 weeks
1011
604
0
50
100
150
200
250
300
350
Re-e
pith
eliali
zatio
n (μ
m)
SSD LM Soft
Application of L-Mesitran Soft resulted in significantly
more re-epithelialization in burns compared to silver
sulphadiazine.
(stage in-
operation was glu-
oduct Informationoduct Information
1011
601
1. First review
2. 29 days after hospital discharge
3. 60 days after hospital discharge
0
5
10
15
20
Absorption Moisture Vapour Transmission Rate (MVTR)Allevyn
g/m
2 (2
4hrs
) X
1.00
0
Total fluid handling(4 REPS 40ºC, 55% RH, 24hrs)
Fluid handling capacity of L-Mesitran Hydro, Border and Active Large
GranuflexL-Mesitran
L-Mesitran Hydro, BorderThe Hydro is a honey containing dressing for use on acute and chronic wounds. L-Mesitran Border isidentical, but with an adhesive border.
Hydro and Border are sterile, semi-permeable wound dressings containing 30% honey, an acrylic polymer gel and water with a polyurethane film backing, with and without an adhesive border.The honey-hydrogel pad donates moisture tore-hydrate dry tissue, and is also able to absorb low to high levels of exudate to help maintain a moist environment conducive to healing. The film backing provides the dressing with bacterial barrier properties. The adhesive border from the Border allows thedressing to be fixed securely. This is useful when patients need to shower or bathe with the dressingin place.
IndicationsBoth Hydro and Border are indicated for chronic wounds, such as:- pressure ulcers- superficial and partial thickness burns- venous, arterial and diabetic ulcers- fungating wounds.
They are also indicated for acute wounds such as:- donor sites- surgical wounds- cuts and abrasions
EfficacyHydro and Border quickly neutralize wound odors. The products provide a moist wound healing environment. This environment aids cleansing of the wound and optimizes wound healing.
The gel does not adhere to the wound. L-Mesitran hasno influence on blood glucose levels. The productshave a cooling effect, which is helpful with e.g. burns.
Case: BurnAn adult male (42 years), with an accidental burn sustained to the right upper extremity, including hand, after falling into a fire drum with hot coals.
MethodsTangential excision or skin grafting was not indicated and the wounds were initially dressed at the hospital with silver impregnated dressings before intentional conversion to L-Mesitran Hydro after hospital discharge. Before and after burn dressing treatment with the honey based dressings, and clinical outcome in this patient, are reflected in figures 1-3.
ResultsSatisfactory wound healing and burn epithelialization was complete in sixty days, and the rehabilitation at home was successful and facilitated by strict sepsis surveillance and nutritional support. Both a positive subjective and objective end result or measured-out-come followed the use of the honey based dressings of choice.
Three month follow-up after the burn showed minimal depigmentation, hyperpigmentation and hyperplastic scar tissue resulting in no elbow, wrist or finger contractures.
DiscussionBurn surface wound healing was affected bysecondary intention and the use of topical honey-based moist dressings, active movements of both extremity joints and hand to avoid contracture
Product InformationHydro & Border
dressing to be fixed securely. This is useful when patients need to shower or bathe with the dressingin place.
Satisfactory wound healing and burn epithelialization onment is gnilaehd
esentation as a sin-
patient comfort
essing can stay
essing changes
The T
and donor
e ulcers, venous and
and/or debride
surgical wounds
wound healing
cleansing of
wound and optimizes wound healing.
wound (it also pr
the wound).
MethodsAt the start of the honey treatment the wound was
ducing high exudates. These exudates removed
changed 1x daily and covered with a foam d
esulted in significantly
ed to silver
was pro-
emoved the
dress-
comfort stay
changes Tulle Tulle T
donor
e ulcers, venous and
debridewounds
healingof
rwound).
was changed 1x daily and covered with
Infected? No
Yes (*)
Is thewoundwet, moistor dry?
Is thewoundwet, moistor dry?
The wound is YELLOW
hydro-active dressings / provide and mantain moist
wound healing environment / supports optimal healing
Wet
Moist
Dryo Soft
o Soft
o Soft
o Tulle / Softo Hydro / Border
o Tulle / Softo Hydro / Border
o Hydro / Border
o Net
SUPERFICIALWOUNDS
DEEPWOUNDS
CHRONIC AND ACUTE WOUNDSClean the wound first (e.g. saline)
Clean the wound first (e.g. saline)
Infected? No
Yes (*)
Wet
Moist
Dry
o Soft / Tulle
o Tulle o Soft
o Tulleo Soft
o Softo Net
o Soft
o Soft
o Soft
o Soft
o Softo Net
The wound is BLACKo provides and maintains a
moist wound environment
o supports debridement
o provides and maintains a
moist wound environment
o supports optimal healing
and debridement
- closed wounds after suturing
- open wounds after suturing
o Hydro / Border POST-OPERATIVE WOUNDS
© Theo Manufacturing 2016 www.l-mesitran.com/us (*) In the event wounds are infected, seek appropriate advice from a physician
when applying L-Mesitran products.
The wound is REDo protective layer
o provides and maintains
a moist environment
o stimulate epithelisation
Wet
Moist
Dry
o Tulle / Soft
o Tulle / Soft o Hydro / Border
o Tulle / Softo Hydro / Border
o Softo Net
o Soft
o Soft
o Soft
o Soft
o Tulle / Soft
Clean the wound first (e.g. saline)
Wound Care Protocol usingL-Mesitran™ honey dressings
An adult male (42 years), with an accidental burn sustained to the right upper extremity, including hand, after falling into a fire drum with hot coals.
Tangential excision or skin grafting was not indicated and the wounds were initially dressed at the hospital with silver impregnated dressings before intentional conversion to L-Mesitran Hydro after hospital discharge. Before and after burn dressing treatment with the honey based dressings, and clinical outcome in this patient, are reflected in figures 1-3.
Satisfactory wound healing and burn epithelialization
Hydro & Border
Satisfactory wound healing and burn epithelialization
An adult male (42 years), with an accidental burn sustained to the right upper extremity, including hand, after falling into a fire drum with hot coals.
Tangential excision or skin grafting was not indicated and the wounds were initially dressed at the hospital with silver impregnated dressings before intentional conversion to L-Mesitran Hydro after hospital discharge. Before and after burn dressing treatment with the honey based dressings, and clinical outcome
Satisfactory wound healing and burn epithelialization
L-Mesitran SoftL-Mesitran Soft is a gel that contains: 40% medical grade honey, hypo-allergenic lanolin, propylene gly-col, PEG 4000, and vitamins C & E.
drawn from the surrounding tissues through osmosis. By doing so, a moist wound healing environment is created. This environment stimulates the wound heal-ing process.
L-Mesitran Soft is a primary wound dressing that can be covered with most commonly used secondary dressings. The properties of the gel also help prevent the secondary dressing adhering to the wound bed.
Indications- Chronic wounds.- Pressure ulcers (Stage I-IV).- Venous stasis ulcers.- Fungating wounds (to help deodorise and/or debride).
- Colonised acute wounds.- Surgical wounds, post-operative wounds.
L-Mesitran Soft provides a moist wound healing en-vironment. This environment aids cleansing of the wound and optimizes wound healing. The gel does not adhere to the wound (it also prevents the secondary dressing adhering to the wound). L-Me-and reduces pain.
Case: Leg ulcerA woman (57) with a general bad health condition and diabetes had an ulcer on her leg after a vein was re-iodine treatment for a week in the IC-unit.
Methods
Soft was applied in a thin layer. This was done by the home care nurse under supervision of the GP. ResultsIn the course of six weeks roughly 150g of L-Mesitran Soft was used and the wound healed. No adverse ef-shows there is little to no scarring. The necrotic and
-mately four weeks a clean and granulating wound bed the next three weeks and after seven weeks the wound pain during wear time or at dressing changes. No mac-
eration was observed and the dressing created a moist wound environment.
DiscussionThe debridement of the wounds was fast, which is one of the key features of honey based products. This eval-uation shows that this product can effectively combat
.noitasilehtipe dna noitalunarg etalumits dna snoitcefniThe wound healed completely without adverse effects and virtually no scarring.
Product InformationSoft
3. After 7 weeks
2. After 4 weeks
1. First review
1011
603
0
50
100
150
200
250
300
350
Re-e
pith
eliali
zatio
n (μ
m)
SSD LM SoftApplication of L-Mesitran Soft resulted in significantly more re-epithelialization in burns compared to silver sulphadiazine.
Case: Leg ulcer
drawn from the surrounding tissues through osmosis. By doing so, a moist wound healing environment is created. This environment stimulates the wound heal-ing process.
L-Mesitran Soft is a primary wound dressing that can be covered with most commonly used secondary dressings. The properties of the gel also help prevent the secondary dressing adhering to the wound bed.
Indications- Chronic wounds.- Pressure ulcers (Stage I-IV).- Venous stasis ulcers.Venous stasis ulcers.V
- Fungating wounds (to help deodorise and/or debride).- Colonised acute wounds.- Surgical wounds, post-operative wounds.
L-Mesitran Soft provides a moist wound healing en-vironment. This environment aids cleansing of the wound and optimizes wound healing. The gel does not adhere to the wound (it also prevents the secondary dressing adhering to the wound). L-Me-and reduces pain.
iodine treatment for a week in the IC-unit. Methods
Soft was applied in a thin layer.r.r Thishome care nurse under supervision of the GResultsIn the course of six weeks roughlySoft was used and the wound healed.
shows there is little to no scarring.mately four weeks a clean and granulatingthe next three weeks and after sevenpain during wear time or at dressingeration was observed and the dressingwound environment.
DiscussionThe debridement of the wounds was fast,of the key features of honey based products.uation shows that this product can effectivelyffectivelyf
nanoitalunargetalumitsdnasnoitcefniThe wound healed completely withoutand virtually no scarring.
3. After 7 weeks
2. After 4 weeks
1. First review
0
50
100
150
200
250
300
350
Re-e
pith
eliali
zatio
n (μ
m)
SSD LM SoftftfApplication of L-Mesitran Soft resulted in significantly more re-epithelialization in burns compared to silver sulphadiazine.
1. First review
2. 29 days after hospital
3. 60 days after hospital
dressing to be fixed securely. This is useful when patients need to shower or bathe with the dressing
Satisfactory wound healing and burn epithelialization was complete in sixty days, and the rehabilitation at home was successful and facilitated by strict sepsis surveillance and nutritional support. Both a positive subjective and objective end result or measured-outcome followed the use of the honey based dressings
Three month follow-up after the burn showed minimal depigmentation, hyperpigmentation and hyperplastic scar tissue resulting in no elbow, wrist or finger contractures.
Burn surface wound healing was affected bysecondary intention and the use of topical honey-based moist dressings, active movements of both extremity joints and hand to avoid contracture
provide and mantain moist
ent / supports optimal healing
o Soft
o Soft
o Soft
Tulle / Softo Hydro / Border
Tulle / Soft Hydro / Border
Hydro / Border
Net
SUPERFICIALWOUNDS
DEEPWOUNDS
o Soft / Tulle
o Tulleo Soft
o Tulleo Soft
o Softo Net
o Soft
o Soft
o Soft
o Soft
o Softo Net
o Hydro / Border
d, seek appropriate advice from a physician
o Tulle / Soft
o Tulle / Softo Hydro / Border
o Tulle / Softo Hydro / Border
o Softo Net
o Soft
o Soft
o Soft
o Soft
o Tulle / Soft
Wound Care Protocol using honey dressingsWound Care Protocol using honey dressingsWound Care Protocol using
1. First
2. 29 days after hospital
3. 60 days after hospital
home was successful and facilitated by strict sepsis surveillance and nutritional support. Both a positive subjective and objective end result or measured-outcome followed the use of the honey based dressings
Three month follow-up after the burn showed minimal depigmentation, hyperpigmentation and hyperplastic scar tissue resulting in no elbow, wrist or finger contractures.
Burn surface wound healing was affected bysecondary intention and the use of topical honey-based moist dressings, active movements of both extremity joints and hand to avoid contracture
Satisfactory wound healing and burn epithelialization was complete in sixty days, and the rehabilitation at home was successful and facilitated by strict sepsis
eview
2. 29 days after hospital
3. 60 days after hospital
Satisfactory wound healing and burn epithelialization was complete in sixty days, and the rehabilitation at home was successful and facilitated by strict sepsis surveillance and nutritional support. Both a positive subjective and objective end result or measured-outcome followed the use of the honey based dressings
Three month follow-up after the burn showed minimal depigmentation, hyperpigmentation and hyperplastic scar tissue resulting in no elbow, wrist or
Burn surface wound healing was affected bysecondary intention and the use of topical honey-based moist dressings, active movements of both extremity joints and hand to avoid contracture
Satisfactory wound healing and burn epithelialization was complete in sixty days, and the rehabilitation at home was successful and facilitated by strict sepsis surveillance and nutritional support. Both a positive
2. 29 days after hospital
3. 60 days after hospital
surveillance and nutritional support. Both a positive subjective and objective end result or measured-outcome followed the use of the honey based dressings
Three month follow-up after the burn showed minimal depigmentation, hyperpigmentation and hyperplastic scar tissue resulting in no elbow, wrist or
Burn surface wound healing was affected bysecondary intention and the use of topical honey-based moist dressings, active movements of both extremity joints and hand to avoid contracture
1
Clinical Data | Tabular summary May 2016
Case StudiesPublished Data for L-MesitranThis tabular summary is a quick guide to published data on L-Mesitran products.The list has been updated for all The most recent publications are listed �rst.
known published data on or before May 5, 2016.
In-vivo clinical studies (human)
Year Author Study type Wound type# patients
Summary
2015 HariKrishna R Non-randomised controlled case studies
carbuncle wounds, burns
4 Four patients with chronic wounds were treated with hon-ey based products. Wounds became clean and healing was noted. Therefore, this is a modality which we can use to get good wound closure. In these cases L-Mesitran Soft was used as it is more gentle and there was no stinging sensation.
2015 Aparício Case report Gliosarcoma, tumors
1 L-Mesitran Soft contributes to less malodor with malig-nant wounds. Patients diagnosed with gliosarcoma has a life expectancy of approximately 12 months. It is im-portant to control the symptoms caused by malignant wounds. Particulary to preserve as much quality of life as possible for the patient. 2015 Rodrigues
Almeida ACCase report Burns 1 L-Mesitran Tulle speeds up the healing process in the management of burns. The product induces better hy-dration and greater elasticity of the skin. After surgical debridement, application of mesh-shaped autografts onto the burned area (the upper leg and hip) and treat-ment with L-Mesitran Soft, the wound healed within 11 days.
2013 Boggust A Prospective Burns(pediatric)
11 Eleven children (6 girls and 5 boys) in the ages 2-15 years were presented to the Paediatric Emergency Department in Woolwich (UK). From March–September 2013 their burns were treated with L-Mesitran Hydro and Border with very good (cosmetic) results. Erythema was reduced, none of the children developed signs of wound infection, and pain reduced over time. Feedback from clinicians, parents and children was overall positive.2013 Belcher J Case report Lower leg ulcer 1 The use of L-Mesitran Net contributed to the autoly-tic debridement of the necrotic tissue on the lower leg wound of the patient. The honey was acceptable to the
of the success of this product it is an option that is now frequently used and included in the wound management formulary of the author.
See our website forother Marketing &
Reference Materialsand Related Links!
Dynarex L-Mesitran Honey